Siemens Healthcare has received FDA clearance for its Virtual Touch imaging ultrasound application.
Siemens Healthcare has received FDA clearance for its Virtual Touch imaging ultrasound application, the company announced.
This is the company’s first commercially available implementation of its Acoustic Radiation Force Impulse technology.
Virtual Touch, which uses sound beams to gently compress tissues, allows clinicians to visualize tissue stiffness, seeing deeper into the body, the company said. The technology displays a map, or elastogram, of relative tissue stiffness. The map is more uniform than manual compression techniques, the company said.
It is available on Siemens’ ACUSON S2000 and ACUSON S3000 systems. It is cleared for use in abdominal, breast, thyroid, small parts and musculoskeletal exams. The technology has been available for use in Europe and Asia since 2008.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.